BORTEZOMIB IN COMBINATION WITH PEGYLATED LIPOSOMAL DOXORUBICIN AND THALIDOMIDE (VDT) FOR THE TREATMENT OF PREVIOUSLY UNTREATED MULTIPLE MYELOMA

被引：0
|
作者：
Ailawadhi, S. [1 ]
Miller, K. C. [1 ]
Depaolo, D. [1 ]
Whitworth, A. [1 ]
Yu, J. [1 ]
Trump, D. L. [1 ]
Padmanabhan, S. [1 ]
Czuczman, M. [1 ]
Bernstein, Z. P. [1 ]
Hernandez-Ilizaliturri, F. [1 ]
Lee, K. [1 ]
Chanan-Khan, A. [1 ]
机构：
[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0208
引用
收藏
页码：83 / 83
页数：1
相关论文
共 50 条
  • [1] Bortezomib in combination with pegylated liposomal doxorubicin and thalidomide (VDT) for the treatment of previously untreated multiple myeloma
    Chanan-Khan, Asher A.
    Miller, Kena C.
    DePaolo, Dawn
    Padmanabhan, Swaminathan
    Whitworth, Amy
    Ailawadhi, Sikander
    Lee, Kelvin
    Czuczman, Myron S.
    [J]. BLOOD, 2007, 110 (11) : 1057A - 1058A
  • [2] Bortezomib in Combination with Pegylated Liposomal Doxorubicin and Thalidomide (VDT), An Effective Steroid Independent Regimen for Previously Untreated Multiple Myeloma Patients: Final Result of a Phase II Study
    Sher, Taimur
    Miller, Kena C.
    Ailawadhi, Sikander
    Manfredi, Debbie
    Wood, Margaret
    Tan, Wei
    Wilding, Gregory
    Liu, Hong
    Czuczman, Myron S.
    Hernandez, Francisco
    Hong, Frederick
    Sood, Raman
    Soniwalla, Saif
    Lawrence, William
    Kouides, Peter A.
    Lee, Kelvin P.
    Chanan-Khan, Asher
    [J]. BLOOD, 2009, 114 (22) : 256 - 256
  • [3] Bortezomib in combination with pegylated liposomal doxorubicin for the treatment of multiple myeloma
    Manochakian, Rarni
    Miller, Kena C.
    Chanan-Khan, Asher Alban
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2007, 7 (04): : 266 - 271
  • [4] Bortezomib in combination with thalidomide-dexamethasone for previously untreated multiple myeloma
    Wang, M.
    Giralt, S.
    Delasalle, K.
    Handy, B.
    Alexanian, R.
    [J]. HEMATOLOGY, 2007, 12 (03) : 235 - 239
  • [5] Bortezomib/pegylated liposomal doxorubicin combinations in multiple myeloma
    Reddy, GK
    D'Orazio, A
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2005, 6 (03): : 170 - 171
  • [6] Bortezomib [VELCADE™], pegylated liposomal doxorubicin [DOXIL/CAELYX®] and dexamethasone in the treatment of previously untreated multiple myeloma patients:: Impact on quality-of-life
    Belch, Andrew
    Reece, Donna E.
    Bahlis, Nizar J.
    White, Darrell
    Teixeira, Bruno
    Camacho, Fernando
    Plante, Richard K.
    [J]. BLOOD, 2007, 110 (11) : 1058A - 1059A
  • [7] A modified regimen of pegylated liposomal doxorubicin, bortezomib and dexamethasone (DVD) is effective and well tolerated for previously untreated multiple myeloma patients
    Berenson, James R.
    Yellin, Ori
    Chen, Chien-Shing
    Patel, Ravi
    Bessudo, Alberto
    Boccia, Ralph V.
    Yang, Hank H.
    Vescio, Robert
    Yung, Elizabeth
    Mapes, Russell
    Eades, Benjamin
    Hilger, James D.
    Wirtschafter, Eric
    Hilger, Jacqueline
    Nassir, Youram
    Swift, Regina A.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2011, 155 (05) : 580 - 587
  • [8] Pegylated liposomal doxorubicin and bortezomib in relapsed/refractory multiple myeloma
    不详
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2007, 7 (07): : 453 - 455
  • [9] A phase II study of a modified pegylated liposomal doxorubicin (PLD), bortezomib and dexamethasone regime for patients with previously untreated multiple myeloma (MM)
    Berenson, J. R.
    Yellin, O.
    Chen, C.
    Patel, R.
    Bessudo, A.
    Boccia, R. V.
    Yang, H.
    Gupta, V.
    Hilger, J.
    Swift, R. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] Bortezomib for the treatment of previously untreated multiple myeloma
    Romano, Alessandra
    Conticello, Concetta
    Di Raimondo, Francesco
    [J]. IMMUNOTHERAPY, 2013, 5 (04) : 327 - 352
12345